• Keine Ergebnisse gefunden

Correction to: Evaluating the Impact and Benefits of Fluticasone Furoate/Vilanterol in Individuals with Asthma or COPD: A Mixed-Methods Analysis of Patient Experiences

N/A
N/A
Protected

Academic year: 2022

Aktie "Correction to: Evaluating the Impact and Benefits of Fluticasone Furoate/Vilanterol in Individuals with Asthma or COPD: A Mixed-Methods Analysis of Patient Experiences"

Copied!
1
0
0

Wird geladen.... (Jetzt Volltext ansehen)

Volltext

(1)

CORRECTION

Correction to: Evaluating the Impact and Benefits of Fluticasone Furoate/Vilanterol in Individuals with Asthma or COPD: A Mixed-Methods Analysis of Patient Experiences

Henrik Svedsater

.

Helen A. Doll

.

Jake Macey

.

Gail Miles

.

Lisa Bradshaw

.

Magdalena Vanya

Published online: September 3, 2021

ÓSpringer Healthcare Ltd., part of Springer Nature 2021

Correction to: Adv Ther (2018) 35:1378–1399

https://doi.org/10.1007/s12325-018-0760-7

There is an error in the DOI link of the original publication. The error has been resolved.

The original article can be found online athttps://doi.

org/10.1007/s12325-018-0760-7.

H. Svedsater (&)

Value Evidence and Outcomes, GSK, GSK House, Brentford, Middlesex, UK

e-mail: henrik.x.svedsater@gsk.com H. A. DollJ. Macey

ICON, ICON Clinical Outcome Assessments, Abingdon, UK

G. Miles

BreathingSpace, Rotherham, UK L. Bradshaw

Centre for Workplace Health, Northern General Hospital, Sheffield, UK

M. Vanya

ICON Plc, San Francisco, CA, USA Adv Ther (2021) 38:5424

https://doi.org/10.1007/s12325-021-01901-9

Referenzen

ÄHNLICHE DOKUMENTE

The group of 53 patients who were treated in-label and guideline-adherent with an iron chelator achieved a survival benefit compared with 24 patients who were eligible accord- ing

capacity of power plants to be installed over a given planning horizon. However in order to calculate the operating costs it is necessary to determine how the existing plants at

Impact of treatment on a Dermatology Life Quality Index (DLQI) a and b Children’s Dermatology Life Quality Index (CDLQI) b band descriptors.. Impact of treatment on a

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any

This needs to be corrected as ‘‘Fess’’.. The publisher regret for

Therefore, the copyright of the article has been changed to © The Author(s) 2020 and the article is forthwith distributed under the terms of the Creative Commons Attribution

The two pieces of graphs can be combined in to a directed acyclic graph that encodes the negative

This Special Issue of curated articles in the Review Journal of Autism and Developmental Disorders (RJAD) focuses on families of individuals with autism spectrum disorder